Zavesca

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 66215-201
  • Package NDC 66215-201-90
  • Application number NDA021348
  • SPL ID f9cb16ee-d325-b331-e053-6394a90ab08c
  • SPL set ID 817892d1-ee12-4632-85fc-57ccdf16d7b8
  • UNII ADN3S497AZ
  • RxCUI 401938
  • RxCUI 541070

What the source publishes

Labeler
Actelion Pharmaceuticals US, Inc.
Active ingredients
miglustat
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:66215-201_f9cb16ee-d325-b331-e053-6394a90ab08c
{
  "name": "Zavesca",
  "splId": "f9cb16ee-d325-b331-e053-6394a90ab08c",
  "labels": [
    {
      "setId": "817892d1-ee12-4632-85fc-57ccdf16d7b8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=817892d1-ee12-4632-85fc-57ccdf16d7b8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=817892d1-ee12-4632-85fc-57ccdf16d7b8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Actelion Pharmaceuticals US, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "6 BLISTER PACK in 1 CARTON (66215-201-90)  / 15 CAPSULE in 1 BLISTER PACK (66215-201-15)",
      "package_ndc": "66215-201-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20030731"
    }
  ],
  "productId": "66215-201_f9cb16ee-d325-b331-e053-6394a90ab08c",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "66215-201",
  "deaSchedule": null,
  "genericName": "miglustat",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "MIGLUSTAT",
      "strength": "100 mg/1"
    }
  ],
  "applicationNumber": "NDA021348",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20030731",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175783",
      "N0000020019",
      "N0000194077",
      "N0000194078"
    ],
    "unii": [
      "ADN3S497AZ"
    ],
    "rxcui": [
      "401938",
      "541070"
    ],
    "spl_set_id": [
      "817892d1-ee12-4632-85fc-57ccdf16d7b8"
    ],
    "pharm_class_epc": [
      "Glucosylceramide Synthase Inhibitor [EPC]",
      "Enzyme Stabilizer [EPC]"
    ],
    "pharm_class_moa": [
      "Glucosylceramide Synthase Inhibitors [MoA]",
      "Enzyme Stabilizers [MoA]"
    ],
    "manufacturer_name": [
      "Actelion Pharmaceuticals US, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:66215-201_f9cb16ee-d325-b331-e053-6394a90ab08c"